Mammalian expression vector comprising the mCMV promoter and first intron of hCMV major immediate early gene

Details for Australian Patent Application No. 2006237193 (hide)

Owner Lonza Biologics plc.

Inventors Norman, Alison; Kalwy, Stephan; Kallmeier, Robert; Gay, Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006237193

PCT Pub. Number WO2006/111387

Priority 0508154.2 22.04.05 GB; 0508802.6 29.04.05 GB

Filing date 20 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 2 February 2012

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/111387 Priority application(s): WO2006/111387

2 February 2012 Application Accepted

  Published as AU-B-2006237193

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006237197-A blood flow controlling apparatus

2006237177-Pharmaceutically active diazepanes